AMINOV, Rustam, Jonathan CAPLIN, Nina CHANISHVILI, Aidan COFFEY, Ian COOPER, Daniel DE VOS, Jiří DOŠKAŘ, Ville-Petri FRIMAN, İpek KURTBӦKE, Roman PANTŮČEK, Jean-Paul PIRNAY, Grégory RESCH, Christine ROHDE, Wilbert SYBESMA and Johannes WITTMANN. Application of bacteriophages. Microbiology Australia. Clayton, VIC, Australia: CSIRO Publishing, vol. 38, No 2, p. 63-66. ISSN 1324-4272. doi:10.1071/MA17029. 2017.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Application of bacteriophages
Authors AMINOV, Rustam (826 United Kingdom of Great Britain and Northern Ireland), Jonathan CAPLIN (826 United Kingdom of Great Britain and Northern Ireland), Nina CHANISHVILI (268 Georgia), Aidan COFFEY (372 Ireland), Ian COOPER (826 United Kingdom of Great Britain and Northern Ireland), Daniel DE VOS (56 Belgium), Jiří DOŠKAŘ (203 Czech Republic, guarantor, belonging to the institution), Ville-Petri FRIMAN (826 United Kingdom of Great Britain and Northern Ireland), İpek KURTBӦKE (36 Australia), Roman PANTŮČEK (203 Czech Republic, belonging to the institution), Jean-Paul PIRNAY (56 Belgium), Grégory RESCH (756 Switzerland), Christine ROHDE (276 Germany), Wilbert SYBESMA (756 Switzerland) and Johannes WITTMANN (276 Germany).
Edition Microbiology Australia, Clayton, VIC, Australia, CSIRO Publishing, 2017, 1324-4272.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 10600 1.6 Biological sciences
Country of publisher Australia
Confidentiality degree is not subject to a state or trade secret
WWW URL
RIV identification code RIV/00216224:14310/17:00097588
Organization unit Faculty of Science
Doi http://dx.doi.org/10.1071/MA17029
UT WoS 000401196800007
Keywords in English Phage therapy; bacteriophage; clinical trials; Nagoya Protocol; food safety; bacterial resistance
Tags NZ, rivok
Tags International impact, Reviewed
Changed by Changed by: Ing. Nicole Zrilić, učo 240776. Changed: 28/3/2018 16:01.
Abstract
The emergence of antibiotic-resistant bacteria and decrease in the discovery rate of novel antibiotics takes mankind back to the ‘pre-antibiotic era’ and search for alternative treatments. Bacteriophages have been one of promising alternative agents which can be utilised for medicinal and biological control purposes in agriculture and related fields. The idea to treat bacterial infections with phages came out of the pioneering work of Félix d‘Hérelle but this was overshadowed by the success of antibiotics. Recent renewed interest in phage therapy is dictated by its advantages most importantly by their specificity against the bacterial targets. This prevents complications such as antibiotic-induced dysbiosis and secondary infections. This article is compiled by the participants of the Expert Round Table conference ‘Bacteriophages as tools for therapy, prophylaxis and diagnostics’ (19–21 October 2015) at the Eliava Institute of Bacteriophage, Microbiology and Virology, Tbilisi, Georgia. The first paper from the Round Table was published in the Biotechnology Journal1. This In Focus article expands from this paper and includes recent developments reported since then by the Expert Round Table participants, including the implementation of the Nagoya Protocol for the applications of bacteriophages.
Links
MUNI/A/0824/2017, interní kód MUName: Podpora výzkumné činnosti studentů molekulární biologie a genetiky 6 (Acronym: MolBiolGen)
Investor: Masaryk University, Category A
PrintDisplayed: 28/3/2024 16:07